Stay updated on SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Sign up to get notified when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.

Latest updates to the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added. The notice about government funding lapse was removed.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding lapse notice with NIH Clinical Center operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange Detected- Added a Show glossary option and updated revision metadata to v3.4.0, with No FEAR Act Data removed.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page shows Revision: v3.3.4, replacing the prior Revision: v3.3.3. No study results or essential content appear to be altered.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3; the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedThe site revision has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.